In addition, PSMD13 significantly decreased in the lesioned skin of vitiligo patients, suggesting that PSMD13 is involved in the skin lesion development process through the NOD-like-receptor signalling pathway, but HMGA1 did not significantly decrease in the lesioned skin. The gene discussed is HMGA1; the disease is vitiligo.